Highlights • Early hscTrop I levels evaluated for NSTEMI diagnosis in non-CAD early presenters.• In this pilot study, a 1-hour absolute delta hs-cTnI of 4 ng/L showed 95% specificity for NSTEMI, though this finding requres validation.• Baseline hscTrop I < 3 ng/L achieved 86% NPV for ruling out early NSTEMI.• Delta hsc...
M. Jeraiby, Johar Iqbal, Ibrahim Ahmed Robadi et al.· Clinics· 0 citations
Findings support the biological plausibility that chronic MP exposure could influence carcinogenic processes, but evidence establishing a causal association remains inadequate, and well-designed mechanistic, epidemiological, and longitudinal investigations are needed to guide evidence-based policies.
Saba Beigh, S. A. Dar, Arshad Jawed et al.· Critical reviews in oncology...· 0 citations
This review summarizes recent advances in CRISPR‐based diagnostics, focusing on Cas12, Cas13, and Cas14, along with key platforms including SHERLOCK, DETECTR, and FELUDA, and discusses their integration with POC technologies such as microfluidic devices, lateral‐flow assays, and smartphone‐based detection systems.
Taru Singh, Akshat Chilkoti, A. Nagar et al.· ChemistrySelect· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.